Highest-materiality recent filing
Agilent appoints Michael Buckner as Chief Legal Officer, replacing Bret DiMarco
Bret DiMarco resigned as Chief Legal Officer and Secretary effective May 4, 2026; will serve as Special Advisor through Dec 1, 2026.
Agilent CLO Bret DiMarco to resign, serve as Special Advisor through Dec 2026
DiMarco resigns as SVP, Chief Legal Officer and Secretary upon new CLO start or Sept 30, 2026.
Agilent CLO Bret DiMarco to step down; will serve as Special Advisor until Dec 1, 2026
Resigns as SVP, CLO & Secretary upon start of new CLO or Sept 30, 2026, whichever earlier.
Agilent shareholders approve board declassification, elect four directors at annual meeting
Shareholders approved declassification of board over three years: 227.3M for, 0.4M against (Proposal 4).
Agilent VP, Corporate Controller and PAO to retire in January 2027
Rodney Gonsalves to retire as VP, Corporate Controller and Principal Accounting Officer in January 2027; exact date TBD.
Agilent Q1 FY2026 revenue $1.80B (+7% YoY), non-GAAP EPS $1.36 (+4%), raises FY guidance
Q1 revenue $1.80B, up 7% reported and 4.4% core YoY; GAAP EPS $1.07 (down 4%), non-GAAP EPS $1.36 (up 4%).
Agilent Q4 revenue $1.86B beats guidance; non-GAAP EPS $1.59 up 9%; initiates FY26 outlook $7.3-7.4B
Q4 revenue $1.86B, +9.4% reported/+7.2% core; GAAP EPS $1.53 (+25%); non-GAAP EPS $1.59 (+9%).
Agilent appoints Adam Elinoff as CFO effective Nov 17; $700k base salary plus equity
Adam S. Elinoff named CFO effective Nov 17, 2025, succeeding interim CFO Rodney Gonsalves.
Agilent beats Q3 with $1.74B revenue, raises FY2025 revenue outlook
Q3 revenue $1.74B, +10.1% reported / +6.1% core, above guidance; GAAP EPS $1.18 (+22%), Non-GAAP EPS $1.37 (+4%).
Agilent discloses interim CFO compensation: $8,654 bi-weekly stipend + $1M RSU grant
Rodeny Gonsalves interim CFO receives $8,654 bi-weekly stipend effective July 31, 2025, during service.
Agilent CFO Bob McMahon to resign effective July 31; Rodney Gonsalves named interim CFO
Bob McMahon, SVP & CFO, resigns effective July 31, 2025; departure for personal/family reasons, not related to accounting or operations.
Agilent Q2 revenue up 6% to $1.67B; Non-GAAP EPS $1.31, +7% YoY; raises FY outlook
Q2 revenue $1.67B (+6% reported, +5.3% core YoY); GAAP EPS $0.75 (-29%), Non-GAAP EPS $1.31 (+7%).
Agilent appoints AstraZeneca CEO Pascal Soriot and Judy Brown to board; Kunz retires.
Pascal Soriot (AstraZeneca CEO) and Judy Gawlik Brown (Downtown Advisory) appointed effective May 21, 2025.
Mr. Soriot was appointed to serve in the class of directors that will stand for re-election at the 2028 Annual Meeting of Stockholders.
Ms. Brown was appointed to serve in the class of directors that will stand for re-election at the 2026 Annual Meeting of Stockholders.
Max materiality 0.80 · Median 0.55 · Most common event leadership